Anti-viral pill 89% effective for high-risk Covid patients: Pfizer
New York: Pfizer Inc. today announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 ...
New York: Pfizer Inc. today announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 ...